Update on the Treatment of Metastatic Urothelial Carcinoma
Platinum-based combination chemotherapy has been the standard of care in the first-line treatment of metastatic urothelial carcinoma (mUC). Treatment of metastatic disease following progression on platinum-based regimens has evolved significantly in the last few years. Clinical trials are currently...
Saved in:
Main Authors: | Nedal Bukhari, Humaid O. Al-Shamsi, Faisal Azam |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-01-01
|
Series: | The Scientific World Journal |
Online Access: | http://dx.doi.org/10.1155/2018/5682078 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Update on Chemotherapy in the Treatment of Urothelial Carcinoma
by: Carrie Costantini, et al.
Published: (2011-01-01) -
Urothelial Carcinoma of the Bladder Metastatic to Bone Marrow Presenting as Isolated Thrombocytopenia
by: Robert C. Chan, et al.
Published: (2007-01-01) -
Plasmacytoid Urothelial Carcinoma of the Bladder Metastatic to the Stomach: A Case Report
by: Philippe Nabbout, et al.
Published: (2012-01-01) -
Corrigendum to “A Rare Presentation of Cardiac Tamponade from Metastatic Urothelial Carcinoma of the Bladder”
by: Sowmya Palam, et al.
Published: (2019-01-01) -
Metastatic Urothelial Carcinoma from Transplanted Kidney with Complete Response to an Immune Checkpoint Inhibitor
by: Ryan S. Chiang, et al.
Published: (2020-01-01)